Johnson and Johnson

Register and reap the benefits

Become a member of the HCSA to gain access to a variety of support tools and services.

Join us

Winter Conference 2022 Countdown

HCSA Job Board

All the latest NHS procurement job opportunities

See the latest jobs..

Johnson & Johnson (NYSE:JNJ)’s Ethicon subsidiary may close a Scottish surgical suture manufacturing plant, taking 400 jobs with it, according to a BBC report.

The decision to close the Livingston, Scotland plant was part of the company’s global restructuring plans, which were announced las January, according to J&J’s medical device division.

“JJMD initiated the consultation process with the regional and local works councils to propose our intent to close the Ethicon ‘Kirkton’ manufacturing site in Livingston, Scotland. This could potentially impact approximately 400 employees, pending the outcome of the consultation process. We have put forth these proposals in the interest of reducing complexity and increasing agility to better serve the needs of customers and patients in today’s evolving healthcare marketplace. We carefully assessed our options and recognize our proposed plans have the potential to significantly affect our employees, their families and the local community. We are committed to supporting them through the consultation process,”

J&J said, according to the report.

UK and Scottish governments are trying to secure the site and keep it from closing, according to the report. If it closes, production will likely shift to larger facilities in Texas, Brazil and Mexico.

“Unfortunately despite our very best efforts, the company has decided to enter into consultation on possible site closure, which is hugely disappointing. Our focus now is on working with J&J to try to find a new owner for the site and on doing all we can to support the affected staff through this difficult period,” economy secretary Keith Brown said, according to the paper.– Mass Device


Date: 20th March 2017